Worldleish
An International Congress on
Leishmania & Leishmaniasis
Why
?
Cutaneous, mucocutaneous and visceral
leishmaniases are seriou
s
diseases, which are vector-borne and wide-spread
in more than 90 countries, putting 350 million
population at risk. WHO estimates
an annual incidence of 2 million and a
total of 12 million current cases. The
causative agents are various species of
trypanosomatid protozoa in the genus of
Leishmania, which are excellent models
for aspects of laboratory studied in
cell/molecular biology, biochemistry,
immunology of host-parasite
interactions.
Who
?
Anyone interested in Leishmania and
leishmaniasis is welcome to participate,
including individuals of private and
public academic institutions, charitable
organizations, advocacy groups,
government officials/ representatives,
for-profit private sectors and their
friends/affiliates.
When/where
?
Every four years preferably in a country endemic to
leishmaniasis.
What ?
Bring laboratory researchers and field
workers from all disciplinary areas
together for sharing new discoveries and
exchange of new ideas. Provide
opportunities of international
collaboration, industrial participation,
charitable donation and training of the
next generation.
 |
SECOND
WORLD CONGRESS ON LEISHMANIOSIS
20-24 May 2001, Crete, GREECE |
|
ORGANIZED BY
UNIVERSITY OF CRETE
HELLENIC PASTEUR INSTITUTE
TURKISH SOCIETY for PARASITOLOGY
|
CONGRESS VENUE
|
Creta Maris Hotel,
Hersonissos, Crete,
Greece
|
|
ORGANIZING COMMITTEE
|
Presidents
|
|
M. Ali Ozcel,
Ege
University Medical Faculty, Turkey
Y.
Tselentis, University of Crete, Greece
|
|
Honorary President
|
|
C. Stournaras, General Director, Hellenic
Pasteur Institute,Greece
|
|
Members
|
|
M.Z. Alkan, Turkey,
K.-P Chang, U.S.A.,
K. Soteriadou, Greece
|
SCIENTIFIC COMMITTEE
|
|
K.-P. Chang (USA),
P. Desjeux (Geneva),
E. Handman (Australia),
C. L. Jaffe (Israel),
R. Killick-Kendrick (UK),
H. Momen (Brasil),
S. G. Reed (USA),
K. Soteriadou (Greece),
K. Stuart (USA)
|
|
|
|
Related Documents
